Microbot Medical® to Open Inaugural Endovascular Robotics Session at the Society of Robotic Surgery Annual Meeting
Microbot Medical Inc. (MBOT)
Last microbot medical inc. earnings: 11/14 03:34 pm
Check Earnings Report
US:NASDAQ Investor Relations:
microbotmedical.com/investors
Company Research
Source: GlobeNewswire
HINGHAM, Mass., July 08, 2025 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer of the innovative LIBERTY® Endovascular Robotic System, announced its participation in the inaugural Endovascular Robotics session at the Society of Robotic Surgery (SRS) annual meeting, being held from July 16-20, in Strasbourg, France. The Company applauds the SRS for recognizing the growing need to spotlight this field, which Microbot believes is being driven by rapid innovation and rising market demand. The panel session, titled: Endovascular Robotics; the next frontier for robotic surgery, will take place at 1:30am CEST on Saturday July 19th and will be moderated by Dr. Adnan Siddiqui, a University of Buffalo Distinguished Professor and Vice Chairman in the Department of Neurosurgery (UBNS) at the State University of New York at Buffalo’s Jacobs School of Medicine and Biomedical Sciences, and Dr. Ryan Madder, Section Chief of Interventional Cardiology and Director of the Cardiac
Show less
Read more
Impact Snapshot
Event Time:
MBOT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MBOT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MBOT alerts
High impacting Microbot Medical Inc. news events
Weekly update
A roundup of the hottest topics
MBOT
News
- Microbot Medical (NASDAQ:MBOT) was upgraded by analysts at Roth Capital to a "strong-buy" rating. They now have a $5.50 price target on the stock.MarketBeat
- Microbot Medical (NASDAQ:MBOT) is now covered by analysts at Roth Capital. They set a "buy" rating on the stock.MarketBeat
- Microbot Medical (NASDAQ:MBOT) had its "buy" rating reaffirmed by analysts at HC Wainwright.MarketBeat
- Microbot Medical® Announces Emory University Hospital as the First Hospital in the World to Adopt the New LIBERTY® Endovascular Robotic SystemGlobeNewswire
- Microbot Medical® Commences the Limited Market Release of its LIBERTY® Endovascular Robotic System in the U.S. GlobeNewswire
MBOT
Sec Filings
- 11/26/25 - Form 8-K
- 11/19/25 - Form 424B3
- 11/19/25 - Form 424B3
- MBOT's page on the SEC website